NTRB NUTRIBAND INC
NUTRIBAND INC (NTRB) is expected to report earnings on December 4, 2026, before the market open.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About NUTRIBAND INC
Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company is engaged in developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. Nutriband Inc. is based in Orlando, United States.
Sector
Healthcare
Industry
Drug Delivery
Charts powered in part by Lightweight Charts™ by TradingView.